When The Mighty Fall, Smaller Vaccine Players Seize The COVID Day
Agile Decisions Make The Difference
While global vaccine heavyweights such as Merck & Co, Sanofi and GSK have somewhat lagged in the development of vaccines for COVID-19, smaller players have stepped up. This is especially true for highly segmented markets such as China, where agility has been important.
